Extended Indications for Lung Volume Reduction Surgery in Advanced Emphysema1 Michael Argenziano, Nader Moazami, Byron Thomashow, Patricia A. Jellen, Lyall A. Gorenstein, Eric A. Rose, Alan D. Weinberg, Kenneth M. Steinglass, Mark E. Ginsburg The Annals of Thoracic Surgery Volume 62, Issue 6, Pages 1588-1597 (December 1996) DOI: 10.1016/S0003-4975(96)00886-7
Fig. 1 Kaplan-Meier actuarial survival (all patients). The Annals of Thoracic Surgery 1996 62, 1588-1597DOI: (10.1016/S0003-4975(96)00886-7)
Fig. 2 Kaplan-Meier actuarial survival: high- versus low-risk groups (severe hypercapnia). (pCO2 = carbon dioxide tension.) The Annals of Thoracic Surgery 1996 62, 1588-1597DOI: (10.1016/S0003-4975(96)00886-7)
Fig. 3 Kaplan-Meier actuarial survival: high- versus low-risk groups (steroid dependence). (Pred = prednisone.) The Annals of Thoracic Surgery 1996 62, 1588-1597DOI: (10.1016/S0003-4975(96)00886-7)
Fig. 4 Kaplan-Meier actuarial survival: high- versus low-risk groups (severe pulmonary dysfunction). (FEV1and FEVpre = preoperative forced expiratory volume in 1 second.) The Annals of Thoracic Surgery 1996 62, 1588-1597DOI: (10.1016/S0003-4975(96)00886-7)
Fig. 5 Kaplan-Meier actuarial survival of high- versus low-risk groups (preoperative rehabilitation [Rehab]). The Annals of Thoracic Surgery 1996 62, 1588-1597DOI: (10.1016/S0003-4975(96)00886-7)